A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 1, Pages 62
Publisher
MDPI AG
Online
2017-01-02
DOI
10.3390/molecules22010062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations and deletions of PRC2 in prostate cancer
- (2016) Payal Jain et al. BIOESSAYS
- A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
- (2016) L A Selth et al. ONCOGENE
- MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer:STAT3andZEB1are upregulated during prostate carcinogenesis
- (2016) Yoon Jin Cha et al. PROSTATE
- Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer
- (2016) Georgios Kallifatidis et al. SEMINARS IN CANCER BIOLOGY
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis
- (2016) Eunsohl Lee et al. NEOPLASIA
- Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells
- (2015) Sang-Hun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy
- (2015) Joaquim Bosch-Barrera et al. CANCER TREATMENT REVIEWS
- Context-dependent actions of Polycomb repressors in cancer
- (2015) M Koppens et al. ONCOGENE
- Epigenetic therapy as a novel approach in hepatocellular carcinoma
- (2015) Ioannis Anestopoulos et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic activities of flavonoids in the prevention and treatment of cancer
- (2015) Christian Busch et al. Clinical Epigenetics
- The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
- (2015) Marjolaine Ngollo et al. BMC CANCER
- Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
- (2015) Cheryl M. Koh et al. Oncotarget
- EZH2: Not EZHY (Easy) to Deal
- (2014) Gauri Deb et al. MOLECULAR CANCER RESEARCH
- The strategies to control prostate cancer by chemoprevention approaches
- (2014) Harold Ting et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Epigenetics of Prostate Cancer: Distribution of Histone H3K27me3 Biomarkers in Peri-Tumoral Tissue
- (2014) Marjolaine Ngollo et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Epigenetic modifications in prostate cancer
- (2014) Marjolaine Ngollo et al. Epigenomics
- Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer
- (2013) Harold Ting et al. AAPS Journal
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Multifaceted role of EZH2 in breast and prostate tumorigenesis
- (2013) Gauri Deb et al. Epigenetics
- High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer
- (2013) XIAOHUI CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells
- (2013) HENRIETTE KAUNTZ et al. Oncology Letters
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- Global Levels of H3K27me3 Track with Differentiation in Vivo and Are Deregulated by MYC in Prostate Cancer
- (2012) Laxmi G. Pellakuru et al. AMERICAN JOURNAL OF PATHOLOGY
- Silibinin – A Promising New Treatment for Cancer
- (2012) Catherine Wing Ying Cheung et al. Anti-Cancer Agents in Medicinal Chemistry
- Epigenetic biomarkers in prostate cancer: Current and future uses
- (2012) Karen Chiam et al. CANCER LETTERS
- Aberrant DNA Methylation and Prostate Cancer
- (2012) Sunipa Majumdar et al. CURRENT GENOMICS
- Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells
- (2012) Samiha Mateen et al. Epigenetics
- The complexity of prostate cancer: genomic alterations and heterogeneity
- (2012) Lara K. Boyd et al. Nature Reviews Urology
- Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma
- (2011) Sebastian Rogenhofer et al. BJU INTERNATIONAL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer
- (2011) Jörg Ellinger et al. CANCER INVESTIGATION
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Epigenetic regulation of prostate cancer
- (2011) Suyin P. Chin et al. Clinical Epigenetics
- Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
- (2010) Ugur Deligezer et al. CLINICA CHIMICA ACTA
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer
- (2010) Thomas W. Flaig et al. PROSTATE
- Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
- (2009) B. D.W. Karanikolas et al. MOLECULAR CANCER RESEARCH
- Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice
- (2009) Wei Cui et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus
- (2008) Ching Tzao et al. MODERN PATHOLOGY
- Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
- (2008) Yongkun Wei et al. MOLECULAR CARCINOGENESIS
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search